Last reviewed · How we verify

NCT05675163: ProteK2t

Antioxidant and Immune Effects of Vitamin K2

Completed NA Last updated 18 June 2023
What this trial tests

NA trial testing Vitamin K2 in Oxidative Stress in 60 participants. Completed in 16 May 2023.

Timeline
15 November 2022
Primary endpoint
16 May 2023
16 May 2023

Quick facts

Lead sponsorNIZO Food Research
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposebasic science
Enrollment60
Start date15 November 2022
Primary completion16 May 2023
Estimated completion16 May 2023
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

NIZO Food Research — full company profile →

Who can join

Adults 50 to 75, any sex, with Oxidative Stress or Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to obtain insight into a dose-dependent effect of vitamin K2 on oxidative stress and specific markers of the immune system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Vitamin K2

Trials testing the same drug.

Other recruiting trials for Oxidative Stress

Currently open trials in the same condition.

Other NIZO Food Research trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05675163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing